Homeostatic control dictates that increased brain usage during the day results in a greater need for slow-wave sleep afterward.
This process is regulated by adenosine, a chemical that accumulates with energy expenditure in the brain.
Adenosine accumulation promotes sleepiness and increases the likelihood and duration of slow-wave sleep.
Caffeine blocks adenosine receptors, preventing adenosine from inducing sleepiness.
Tolerance to caffeine develops as the brain produces more adenosine receptors to compensate for the blockage.
Medications causing tiredness don't necessarily affect adenosine clearance; they can interfere with the sleep-wake flip-flop by:
Reducing the effectiveness of arousal systems.
Increasing the effectiveness of sleep-promoting systems.
The length of the sleep cycle varies among individuals due to genetic and experiential differences.
Adenosine deaminase is an enzyme that breaks down adenosine during slow-wave sleep; variations in its activity influence sleep duration.
Boosting adenosine deaminase function to reduce sleep need is not feasible because:
Adenosine is merely a signal to initiate slow-wave sleep, not the sleep itself.
Slow-wave sleep is essential for clearing toxic metabolites that accumulate in the brain during active functioning.
During slow-wave sleep, the space between neurons increases, facilitating metabolite clearance, a process incompatible with active brain function.
Adenosine triggers slow-wave sleep by inhibiting cells that inhibit the ventrolateral preoptic area (VLPO).
Removing adenosine doesn't eliminate the need for slow-wave sleep; it only eliminates the signal.
Brain temperature and exercise studies show a link between increased brain metabolism and subsequent slow-wave sleep.
Increased brain activity leads to more slow-wave sleep, regulated by adenosine.
Adenosine buildup results from increased activity and triggers the brain to enter the slow-wave sleep state, which clears metabolites such as amyloid-beta.
Dreaming predominantly occurs in REM sleep, with minimal dreaming in slow-wave sleep.
Muscle paralysis is exclusive to REM sleep, distinguishing it from the relaxed state of slow-wave sleep.
Waking up briefly during a dream and falling back asleep allows resumption of the dream because the brain remains in a similar state to REM sleep.
However, engaging in activities before returning to sleep disrupts the continuity of the dream.
Valproate regulates sleep in the brain.
REM sleep behavior disorder involves acting out dreams due to the absence of muscle paralysis, while other aspects of REM sleep remain intact.
The magnocellular nucleus is responsible for muscle paralysis during REM sleep.
Allostatic control refers to the influence of threats to survival on the sleep-wake cycle, primarily driven by:
Hunger
The stress response
Leptin, produced by fat cells, signals energy availability and inhibits hypocretin neurons, favoring sleep.
Leptin uparrow, Sleep uparrow
Ghrelin, produced by an empty stomach, stimulates hypocretin neurons, promoting wakefulness.
Ghrelin uparrow, Wakefulness uparrow
Hypocretin, also known as orexin, was initially believed to signal hunger but primarily functions to prevent sleep in order to find food.
A heightened Orexin level leads to prevented sleep, which allows one to seek food.
Stress activates the medial prefrontal cortex and central extended amygdala, which stimulate hypocretin and noradrenergic neurons, promoting wakefulness.
Stress uparrow, Wakefulness uparrow
The stress response prepares the body to deal with threats by:
Increasing heart rate
Raising blood pressure
Promoting wakefulness
Circadian control governs the rhythmic nature of sleep, making it easier to fall asleep at night than during the day.
This rhythm persists even without external cues, indicating an endogenous biological clock.
The circadian rhythm is approximately 24 hours long, slightly longer for most people.
Exposure to light and dark synchronizes the internal clock with the external world.
The suprachiasmatic nucleus (SCN) in the hypothalamus serves as the primary biological clock.
Endogenous refers to processes internal to an organism.
The SCN is located near the optic chiasm, where optic nerves cross.
All vertebrates possess an SCN.
Damage to the SCN disrupts the organization of the sleep-wake cycle, resulting in ultradian sleep-wake cycles.
The homeostatic control is still present.
During the day, the SCN exhibits high action potential activity, while it is quiet during the night.
SCN cells maintain a 24-hour rhythm even when isolated in a dish, indicating intrinsic rhythm generation.
Individual SCN cells have slightly varying rhythms but communicate to synchronize.
Hamsters with a 20-hour circadian rhythm have SCN cells that also exhibit a 20-hour cycle.
Transplanting SCN cells from a hamster with a normal (24-hour) circadian rhythm to a hamster with a damaged SCN restores the circadian cycle.
Transplanting SCN cells from a 20-hour hamster into a normal hamster causes the recipient to adopt a 20-hour rhythm.
The core components of the SCN clock involve genes and proteins: period 1, 2, and 3 (Per1, Per2, Per3), cryptochrome 1 and 2 (Cry1, Cry2), clock, and BMAL1.
Clock and BMAL1 proteins form a complex that stimulates the transcription of Per and Cry genes into messenger RNA (mRNA) in the nucleus.
mRNA exits the nucleus and is translated into Per and Cry proteins in the cytoplasm.
Per and Cry proteins form complexes that re-enter the nucleus.
Cryptochrome-period one complexes suppress the function of Clock and BMAL1, reducing transcription of Per and Cry genes. This creates a negative feedback loop.
The process from transcription to suppression takes approximately 12 hours, with a full cycle lasting about 24 hours.
Enzymes clear the proteins, and the cycle restarts when protein concentrations are low enough.
The concentration of cryptochrome and period proteins rises until production stops, followed by clearing, and the cycle restarts, maintaining a 24-hour rhythm.
Period two stimulates the transcription of BMAL1, leading to BML1 protein.
As cryptochrome and period proteins increase and suppress the transcription of cryptochrome and period genes, BMAL1 transcription is stimulated.
It creates two cycles operating in anti-phase: one stimulates the production of period and cryptochrome, while the other inhibits their production.
RNA levels of period and cryptochrome fluctuate during the day, with protein levels peaking about six hours later. BMAL1 RNA peaks about 12 hours after period and cryptochrome RNA.
The speed of production and clearing sets a rhythm close to 24 hours, maintaining rhythm in SCN neurons.